Aveanna Healthcare vs BrightSpring Health Services
AVAH and BTSG side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AVAH and BTSG compare
BrightSpring Health Services is the larger company, worth 4.6 times as much as Aveanna Healthcare ($13.2B against $2.9B).
On earnings, Aveanna Healthcare is cheaper: it trades at 10.7× trailing earnings, against 36.4× for BrightSpring Health Services.
BrightSpring Health Services grew revenue faster over the last twelve months (26.0% versus 19.5% for Aveanna Healthcare).
Aveanna Healthcare keeps more of each dollar of sales as profit, with a net margin of 10.6% compared with 2.7% at BrightSpring Health Services.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AVAH | BTSG |
|---|---|---|
| Size and price | ||
| Market cap | $2.9B | $13.2B |
| Share price | $13.16 | $66.89 |
| Change, 1 year | 33.5% | 96.4% |
| Change, 5 years | 57.4% | – |
| Beta (5Y) | 1.41 | 1.05 |
| Employees | 32K | 24K |
| StockData Score | ||
| Total score | 11 | 11 |
| Valuation score | 3 (better) | 1 |
| Growth score | 3 | 3 |
| Performance score | 4 | 4 |
| Health score | 1 | 3 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 10.7× (better) | 36.4× |
| P/S | 1.1× | 0.9× (better) |
| P/B | 10.0× | 6.1× (better) |
| EV/EBITDA | 14.3× (better) | 21.7× |
| P/FCF | – | 26.9× |
| FCF yield | – | 3.7% |
| Fair value | $22.07 | $46.01 |
| Margin of safety | 40.4% (better) | −45.4% |
| Growth | ||
| Revenue growth (TTM) | 19.5% | 26.0% (better) |
| Revenue growth, 5Y average | 10.2% | – |
| Net income growth (TTM) | 1381% (better) | 217% |
| EPS growth (TTM) | 1267% (better) | 202% |
| Profitability | ||
| Gross margin | 32.3% (better) | 12.5% |
| Operating margin | 10.5% (better) | 3.4% |
| Net margin | 10.6% (better) | 2.7% |
| FCF margin | – | 3.2% |
| Return on equity | 200% (better) | 20.5% |
| Return on invested capital | 20.6% (better) | 11.0% |
| Financial health | ||
| Debt / equity | 4.52 | 1.00 (better) |
| Net debt / EBITDA | 4.21 | 2.16 (better) |
| Interest coverage | 2.2× | 3.6× (better) |
| Current ratio | 1.16 | 1.62 (better) |
| Altman Z-score | 1.94 | 4.89 (better) |
| Piotroski F-score | 7 | 7 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 93.0% | 105% |
| Held by insiders | 16.9% | 36.2% |
| Insider net buying, 12 months | −$782M (better) | −$3.4B |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 3.1% | – |
Go deeper
- AVAH stock overview
- AVAH income statement
- AVAH valuation and score
- BTSG stock overview
- BTSG income statement
- BTSG valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.